The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate

Molecular and Cellular Biology

Volumn 16, Issue 8, 1996, Pages 4264-4272

  Fallaux, Frits J ^a   Hoeben, Rob C ^a   Cramer, Steve J ^a   Van Den Wollenberg, Diana J M ^a   Briët, Ernest ^b,c   Van Ormondt, Hans ^a   Van Der Eb, Alex J ^a,d  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Dept Molec Cell Biol Leiden U   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BUTYRIC ACID; COMPLEMENTARY DNA; NUCLEAR FACTOR;

ARTICLE; BLOOD CLOTTING; DNA REPLICATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; PRIORITY JOURNAL; REPRESSOR GENE; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0029896502     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.8.4264     Document Type: Article

References (49)

1. Amati, B., and S. M. Gasser. 1990. Drosophila scaffold-attached regions bind nuclear scaffolds and can function as ARS elements in both budding and fission yeasts. Mol. Cell. Biol. 10:5442-5454.
2. Auffray, C., and F. Rougeon. 1980. Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor DNA. Eur. J. Biochem. 107:303-314.
3. Bernards, R. 1991. N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma. EMBO J. 10:1119-1125.
4. Birren, B. W., S. J. Taplitz, and H. R. Herschman. 1987. Butyrate-induced changes in nuclease sensitivity of chromatin cannot be correlated with transcriptional activation. Mol. Cell. Biol. 7:3863-3870.
5. Bohan, C. A., R. A. Robinson, P. A. Luciw, and A. Srinivasan. 1989. Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat. Virology 172:573-583.
6. Boulikas, T. 1992. Chromatin and nuclear matrix in development and in carcinogenesis: a theory. Int. J. Oncol. 1:357-372.
7. Cockerill, P. N., and W. T. Garrard. 1986. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44:273-282.
8. Cockerill, P. N., and W. T. Garrard. 1986. Chromosomal loop anchorage sites appear to be evolutionary conserved. FEBS Lett. 204:5-7.
9. Connelly, S., T. A. G. Smith, G. Dhir, J. M. Gardner, M. G. Mehaffey, K. S. Zaret, A. McClelland, and M. Kaleko. 1995. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum. Gene Ther. 6:185-193.
10. Croston, G. E., L. A. Kerrigan, L. M. Lira, D. R. Marshak, and J. T. Kadonaga. 1991. Sequence-specific antirepression of histone HI-mediated inhibition of basal RNA polymerase II transcription. Science 251:643-649.
11. Dorner, A. J., L. C. Wasley, and R. J. Kaufman. 1989. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J. Biol. Chem. 264:20602-20607.
12. Dorner, A. J., L. C. Wasley, and R. J. Kaufman. 1990. Protein dissociation from GRP78 and secretion are blocked by depiction of cellular ATP levels. Proc. Natl. Acad. Sci. USA 87:7429-7432.
13. Dwarki, V. J., P. Belloni, T. Nijjar, J. Smith, L. Couto, M. Rabier, S. Clift, A. Berns, and L. K. Cohen. 1995. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proc. Natl. Acad. Sci. USA 92:7429-7432.
14. Fackelmayer, F. O., K. Dahm, A. Renz, U. Ramsperger, and A. Richter. 1994. Nucleic-acid-binding properties of hnRNP-U/SAF-A, a nuclear-matrix protein which binds DNA and RNA in vivo and in vitro. Eur. J. Biochem. 211:749-757.
15. Fallaux, F. Unpublished data.
16. Fallaux, F. J., R. C. Hoeben, and E. Briët. 1995. State and prospects of gene therapy for the hemophilias. Thromb. Haemostasis 74:263-273.
17. Fishel, B. R., A. O. Sperry, and W. T. Garrard. 1993. Yeast calmodulin and a conserved nuclear protein participate in the in vivo binding of a matrix association region. Proc. Natl. Acad. Sci. USA 90:5623-5627.
18. Fort, P., L. Marty, M. Piechaczyk, S. El Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenie family. Nucleic Acids Res. 13:1431-1441.
19. Foss, M., F. J. McNally, P. Laurenson, and J. Rine. 1993. Origin recognition complex (ORC) in transcriptional silencing and DNA replication in S. cerevisiae. Science 262:1838-1844.
20. Gasser, S. M., B. B. Amati, M. E. Cardenas, and J. F. Hofmann. 1989. Studies on scaffold attachment sites and their relation to genome function. Int. Rev. Cytol. 119:57-96.
21. Gorman, C. 1985. High efficiency gene transfer into mammalian cells, p. 143-190. In D. M. Glover (ed.), DNA cloning: a practical approach, vol. II. IRL Press, Oxford.
22. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
23. Hoeben, R. C., F. J. Fallaux, S. J. Cramer, D. J. M. van den Wollenberg, H. van Ormondt, E. Briët, and A. J. van der Eb. 1995. Expression of the blood-clotting factor VIII cDNA is repressed by a transcriptional silencer located in its coding region. Blood 85:2447-2454.
24. Hoeben, R. C., A. A. J. Migchielsen, R. C. van der Jagt, H. van Ormondt, and A. J. van der Eb. 1991. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol. 65:904-912.
25. Hoeben, R. C., D. Valerio, A. J. van der Eb, and H. van Ormondt. 1992. Gene therapy for human inherited disorders: techniques and status. Crit. Rev. Oncol. Hematol. 13:33-54.
26. Hoeben, R. C., R. C. van der Jagt, F. Schoute, N. H. van Tilburg, M. P. Verbeet, E. Briët, H. van Ormondt, and A. J. van der Eb. 1990. Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer. J. Biol. Chem. 265:7318-7323.
27. Hofmann, J. F. X., and S. M. Gasser. 1991. Identification and purification of a protein that binds the yeast ARS consensus sequence. Cell 65:1-10.
28. Israel, D. I., and R. J. Kaufman. 1990. Retroviral-mediated transfer and amplification of a functional human factor VIII gene. Blood 75:1074-1080.
29. Izzaurralde, E., E. Käs, and U. K. Laemmli. 1989. Highly preferential nucleation of histone H1 assembly of scaffold-associated regions. J. Mol. Biol. 210:573-585.
30. Kaufman, R. J., L. C. Wasley, M. V. Davies, R. J. Wise, D. I. Israel, and A. J. Dorner. 1989. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol. Cell. Biol. 9:1233-1242.
31. Kaufman, R. J., L. C. Wasley, and A. J. Dorner. 1988. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263:6352-6362.
32. Klehr, D., T. Schlake, K. Maass, and J. Bode. 1992. Scaffold-attached regions (SAR elements) mediate transcriptional effects due to butyrate. Biochemistry 31:3222-3229.
33. Koeberl, D. D., C. L. Halbert, A. Krumm, and A. D. Miller. 1995. Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation. Hum. Gene Ther. 6:469-479.
34. Kruh, J. 1982. Effects of sodium butyrate, a new pharmacologie agent, on cells in culture. Mol. Cell. Biochem. 42:65-82.
35. Li, J. J., and I. Herskowitz. 1993. Isolation of ORC6, a component of the yeast origin recognition complex, by a one-hybrid system. Science 262:1870-1874.
36. Lusher, J. M., S. Arkin, C. F. Abildgaard, and R. S. Schwartz. 1993. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. N. Engl. J. Med. 328:453-459.
37. Lynch, C. M., D. I. Israel, R. J. Kaufman, and A. D. Miller. 1993. Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Hum. Gene Ther. 4:259-272.
38. Newlon, C. S., and J. F. Theis. 1993. The structure and function of yeast ARS elements. Curr. Opin. Genet. Dev. 3:752-758.
39. Olsen, J. C., and J. Sechelski. 1995. Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum. Gene Ther. 6:1195-1202.
40. Peake, I. R., D. P. Lillicrap, V. Boulyjenkov, E. Briët, V. Chan, E. K. Ginter, E. M. Kraus, R. Ljung, P. M. Mannucci, K. Nicolaides, and E. G. Tuddenham. 1993. Haemophilia - strategies for carrier detection and prenatal diagnosis. Bull. W. H. O. 71:429-458.
41. Pittman, D. D., E. M. Alderman, K. N. Tomkinson, J. H. Wang, A. R. Giles, and R. J. Kaufman. 1993. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood 81:2925-2935.
42. Rosendaal, F. R., C. Smit, and E. Briët. 1991. Hemophilia treatment in historical perspective: a review of medical and social developments. Ann. Hematol. 62:5-15.
43. Thompson, A. R., T. D. Palmer, C. M. Lynch, and A. D. Miller. 1991. Gene transfer as an approach to cure patients with hemophilia A or B. Curr. Stud. Hematol. Blood Transfus. 58:59-62.
44. Tuddenham, E. G., D. N. Cooper, J. Gitschier, M. Higuchi, L. W. Hoyer, A. Yoshioka, I. R. Peake, R. Schwaab, K. Olek, H. H. Kazazian, J.-M. Lavergne, F. Giannelli, and S. E. Antonarakis. 1991. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res. 19:4821-4833.
45. Van Houten, J. V., and C. S. Newlon. 1990. Mutational analysis of the consensus sequence of a replication origin from yeast chromosome III. Mol. Cell. Biol. 10:3917-3925.
46. Vassetzky, Y. S., C. V. de Muura Gallo, A. N. Bogdanova, S. V. Razin, and K. Scherrer. 1993. The sequence-specific nuclear matrix binding factor F6 is a chicken GATA-like protein. Mol. Gen. Genet. 238:309-314.
47. Wood, W. I., D. J. Capon, C. C. Simonsen, D. L. Eaton, J. Gilschier, B. Keyt, P. H. Seeburg, D. H. Smith, P. Hollingshead, K. L. Wion, et al. 1984. Expression of active human factor VIII from recombinant DNA clones. Nature (London) 312:330-337.
48. Yeivin, A., D. Tang, and M. W. Taylor. 1992. Sodium butyrate selectively induces transcription of promoters adjacent to the MoMSV viral enhancer. Gene 116:159-164.
49. Zatloukal, K., M. Cotten, M. Berger, W. Schmidt, E. Wagner, and M. L. Birnstiel. 1994. In vivo production of human factor VIII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery. Proc. Natl. Acad. Sci. USA 91:5148-5152.